Study phase | Screening visit | Baseline- intervention | Washout | Crossover- intervention | Follow-up | Early termination visit |
---|---|---|---|---|---|---|
Visit window | <30 days after Visit 1 | +/ − 3 days 28 days after Visit 2 | +/ − 3 days 28 days after Visit 3 | +/ − 3 days 28 days after Visit 4 | ||
Informed consent/assent | X | |||||
Inclusion/exclusion criteria | X | |||||
Historical data/demographics | X | |||||
Random C-peptide concentration | X | X | ||||
Randomization | X | |||||
Pregnancy test for females of childbearing age | X | X | X | X | X | X |
Current medical data | X | X | X | X | X | X |
Pubertal Tanner staging with physical exam | X | X | X | |||
Ht/Wt measurement and vitals | X | X | X | X | X | X |
Supervised CGM insertion (and training, if applicable, on use) | X | X | ||||
C-peptide by 2-h MMTT | X | X | X | |||
HbA1c | X | X | X | |||
Blood samples for biomarkers (PI:C and INS DNA) | X | X | X | X | X | |
Provision of HAMS-AB | X | X | ||||
CGM download | X | X | X | |||
Stool samples | X | X | X | X | X | |
PBMCs for MAIT cell testing | X | X | X | X | X | |
Serum and plasma for storage | X | X | X | X | X | |
Adverse event assessment | X | X | X | X | X | |
Online dietary assessments | X | X | X | X | X | |
Verbal diet recall | X | |||||
Sampling of prebiotic | X |